Search research articles
Contact Us
Filters
Showing results (61-70 of 92) with videos related to
Page
of 10
Sort By:
Cancer Research
|
March 14, 2001
Chemoprevention of intestinal polyposis in the Apcdelta716 mouse by rofecoxib, a specific cyclooxygenase-2 inhibitor
M Oshima, N Murai, S Kargman, et al.
Archives of Biochemistry and Biophysics
|
June 20, 1998
Structural characterization of the covalent attachment of leukotriene A3 to leukotriene A4 hydrolase
J A Mancini, R J Waugh, J A Thompson, et al.
Journal of Bacteriology
|
March 1, 1985
Polycistronic mRNAs code for polypeptides of the Vibrio harveyi luminescence system
C M Miyamoto, A D Graham, M Boylan, et al.
Prostaglandins
|
October 1, 1986
Leukotriene B3, leukotriene B4 and leukotriene B5; binding to leukotriene B4 receptors on rat and human leukocyte membranes
S Charleson, J F Evans, R J Zamboni, et al.
Cancer Research
|
August 17, 2001
Suppression of intestinal polyps in Msh2-deficient and non-Msh2-deficient multiple intestinal neoplasia mice by a specific cyclooxygenase-2 inhibitor and by a dual cyclooxygenase-1/2 inhibitor
G Lal, C Ash, K Hay, et al.
Molecular Pharmacology
|
February 1, 1992
5-Lipoxygenase-activating protein is the target of a novel hybrid of two classes of leukotriene biosynthesis inhibitors
J A Mancini, P Prasit, M G Coppolino, et al.
Journal of Lipid Mediators
|
March 1, 1993
A new class of leukotriene biosynthesis inhibitor: the development of MK-0591
P Prasit, M Belley, M Blouin, et al.
Nature
|
January 18, 1990
Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesis
R A Dixon, R E Diehl, E Opas, et al.
The Journal of Experimental Medicine
|
December 1, 1993
5-lipoxygenase and 5-lipoxygenase-activating protein are localized in the nuclear envelope of activated human leukocytes
J W Woods, J F Evans, D Ethier, et al.
Cell
|
November 29, 1996
Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)
M Oshima, J E Dinchuk, S L Kargman, et al.
Page
of 10
Search research articles
Search
Showing results (61-70 of 92) with videos related to
Sort By:
Page
of 10
Cancer Research
|
March 14, 2001
Chemoprevention of intestinal polyposis in the Apcdelta716 mouse by rofecoxib, a specific cyclooxygenase-2 inhibitor
M Oshima, N Murai, S Kargman, et al.
Archives of Biochemistry and Biophysics
|
June 20, 1998
Structural characterization of the covalent attachment of leukotriene A3 to leukotriene A4 hydrolase
J A Mancini, R J Waugh, J A Thompson, et al.
Journal of Bacteriology
|
March 1, 1985
Polycistronic mRNAs code for polypeptides of the Vibrio harveyi luminescence system
C M Miyamoto, A D Graham, M Boylan, et al.
Prostaglandins
|
October 1, 1986
Leukotriene B3, leukotriene B4 and leukotriene B5; binding to leukotriene B4 receptors on rat and human leukocyte membranes
S Charleson, J F Evans, R J Zamboni, et al.
Cancer Research
|
August 17, 2001
Suppression of intestinal polyps in Msh2-deficient and non-Msh2-deficient multiple intestinal neoplasia mice by a specific cyclooxygenase-2 inhibitor and by a dual cyclooxygenase-1/2 inhibitor
G Lal, C Ash, K Hay, et al.
Molecular Pharmacology
|
February 1, 1992
5-Lipoxygenase-activating protein is the target of a novel hybrid of two classes of leukotriene biosynthesis inhibitors
J A Mancini, P Prasit, M G Coppolino, et al.
Journal of Lipid Mediators
|
March 1, 1993
A new class of leukotriene biosynthesis inhibitor: the development of MK-0591
P Prasit, M Belley, M Blouin, et al.
Nature
|
January 18, 1990
Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesis
R A Dixon, R E Diehl, E Opas, et al.
The Journal of Experimental Medicine
|
December 1, 1993
5-lipoxygenase and 5-lipoxygenase-activating protein are localized in the nuclear envelope of activated human leukocytes
J W Woods, J F Evans, D Ethier, et al.
Cell
|
November 29, 1996
Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)
M Oshima, J E Dinchuk, S L Kargman, et al.
Page
of 10